Akorn Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Akorn Inc.

Akorn Inc. | Ownership

Companies that own Akorn Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

BlackRock Fund Advisors

9,899,099

7.89%

2,167,305

0.01%

06/30/2018

The Vanguard Group, Inc.

8,298,311

6.62%

353,174

06/30/2018

Fidelity (Canada) Asset Management ULC

7,538,000

6.01%

-3,970,000

0.18%

03/31/2018

Gardner Lewis Asset Management LP

3,760,169

-114,218

5.56%

06/30/2018

SSgA Funds Management, Inc.

3,684,296

2.94%

288,268

06/30/2018

CNH Partners LLC

3,033,939

2.42%

39,300

0.83%

06/30/2018

Marshall Wace LLP

2,069,385

1.65%

1,478,959

0.4%

06/30/2018

Melqart Asset Management (UK) Ltd.

2,011,049

1.6%

623,361

2.82%

06/30/2018

Paulson & Co., Inc.

1,760,000

1.4%

1,760,000

0.52%

06/30/2018

Stonehill Capital Management LLC

1,600,000

1.27%

1,600,000

9.86%

06/30/2018

About Akorn

View Profile

Address	1925 West Field Court Lake Forest Illinois 60045 United States
Employees	-
Website	http://www.akorn.com
Updated	07/08/2019
Akorn, Inc. operates as a niche pharmaceutical company that develops, manufactures and markets generic and prescription pharmaceuticals, as well as, animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.